Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children

NCT02497716 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombosis

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939

Sponsor

Bayer

Collaborators

[object Object]